Will you have Ischaemic nephropathy with Betapace - from FDA reports


Ischaemic nephropathy is reported only by a few people who take Betapace. We study 2,436 people who have side effects while taking Betapace from FDA. Among them, 1 have Ischaemic nephropathy. Find out below who they are, when they have Ischaemic nephropathy and more.

What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on sotalol hydrochloride (the active ingredients of Betapace) and Betapace (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Ischaemic nephropathy are also considered in the study.

What is Betapace?

Betapace has active ingredients of sotalol hydrochloride. It is often used in atrial fibrillation/flutter. (latest outcomes from Betapace 2,556 users)

What is Ischaemic nephropathy?

Ischaemic nephropathy (damage to or disease of a kidney from insufficient blood supply) has been reported by people with quit smoking, stress and anxiety, pain in extremity, chronic obstructive pulmonary disease, schizophrenia, paranoid type (latest reports from 34 Ischaemic nephropathy patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.

On Mar, 14, 2019

2,436 people reported to have side effects when taking Betapace.
Among them, 1 person (0.04%) has Ischaemic nephropathy

Number of reports submitted per year:

Could Betapace cause Ischaemic nephropathy?

Gender of people who have Ischaemic nephropathy when taking Betapace *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Ischaemic nephropathy when taking Betapace *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top co-used drugs for these people *:

  1. Zoloft: 1 person, 100.00%
  2. Rocephin: 1 person, 100.00%
  3. Pravachol: 1 person, 100.00%
  4. Plavix: 1 person, 100.00%
  5. Megace: 1 person, 100.00%
  6. Lasix: 1 person, 100.00%
  7. Flagyl: 1 person, 100.00%
  8. Digoxin: 1 person, 100.00%
  9. Coumadin: 1 person, 100.00%
  10. Cipro: 1 person, 100.00%

Top other side effects for these people *:

  1. Urination - Excessive Volume: 1 person, 100.00%
  2. Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 1 person, 100.00%
  3. Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 100.00%
  4. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 100.00%
  5. Gastritis (inflammation of stomach): 1 person, 100.00%
  6. Gastric Polyps (abnormal growth of stomach tissue projecting from a mucous membrane): 1 person, 100.00%
  7. Gait Disturbance: 1 person, 100.00%
  8. Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 1 person, 100.00%
  9. Electrocardiogram T Wave Abnormal: 1 person, 100.00%
  10. Electrocardiogram Qt Prolonged: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you have Ischaemic nephropathy while taking Betapace?

You are not alone:

Related publications that referenced our studies

Related studies

Drugs that are associated with Ischaemic nephropathy
Ischaemic nephropathy (58 drugs)
Could your condition cause Ischaemic nephropathy
Ischaemic nephropathy (17 conditions)
Betapace side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Betapace
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Betapace and have Ischaemic nephropathy

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...


Thank you!